| African American women** |
No lesion |
CIN1 |
CIN2/3 |
| |
n=202 (41%) |
n=210 (42%) |
n=82 (17%) |
| High-risk HPV type |
ORs (95%CI), p-value |
ORs (95%CI), p-value |
ORs (95%CI), p-value |
| 16/18 |
0.59 (0.18-1.90), 0.38 |
0.54 (0.17-1.67), 0.28 |
0.22 (0.05-0.95), 0.04 |
| 45/33/58/35/68 |
3.45 (1.23-9.68), 0.01 |
4.78 (1.75-13.03), <0.01 |
1.22 (0.32-4.61), 0.76 |
| 31/39/51/52/56/59/66 |
1.46 (0.71-2.99), 0.29 |
0.69 (0.31-1.51), 0.35 |
1.63 (0.42-6.28), 0.47 |
*Adjusted for age, oral contraceptive use, parity and current
smoking (vaccinated women (n=73) were excluded from the analysis)
**Referents were European American women |
